Key result
Inhibition of CaMKII with AC3-I in mice reduced cardiac CaMKII activity by ~40% and preserved left ventricular function after myocardial infarction compared to controls.
Why the study?
Does CaMKII inhibition with AC3-I improve left ventricular function after myocardial infarction in mice?
Does CaMKII inhibition with AC3-I improve left ventricular function after myocardial infarction in mice?
Answers are grounded in this paper and cite their sources.
Inhibition of CaMKII preserves left ventricular function and myocyte calcium handling after myocardial infarction in mice, highlighting its potential as a therapeutic target in cardiac disease.
Ca2+-calmodulin-dependent protein kinases II (CaMKII) expression and activity is increased in cardiac tissue from patients with dilated cardiomyopathy. Mice that have had the conserved region of the CaMKII regulatory domain targeted with an inhibitory peptide, AC3-inhibitor (AC3-I), have normal cardiac development and function. Total levels of CaMKII protein in homogenates of the hearts of AC3-I, AC3-control (AC3-C) and wild-type mice were not different, but the CaMKII activity in cardiac homogenates was reduced by ∼ 40% in the AC3-I. After myocardial infarction, better left ventricular function (fractional shortening) was retained in the AC3-I than AC3-C or wild-type mice. Electrophysiology studies showed that the surviving myocytes from wild-type mice had increased resting [Ca2+]i and reduced peak [Ca2+]i, which are characteristics of severe structural heart disease, whereas these parameters were preserved in surviving myocytes from AC3-I mice. CaMKIIδ inhibition is a promising new approach to cardiac disease. However, in order to be able to exploit the clinical potential of this approach, selective inhibitors of the cardiac CaMKIIδ will need to be developed.
No takes yet. Share an insight, caveat, or question.
Sheila A Doggrell (2005) studied myocardial infarction. AC3-inhibitor (AC3-I) vs. AC3-control (AC3-C) and wild-type mice was evaluated on left ventricular function (fractional shortening). Inhibition of CaMKII with AC3-I in mice reduced cardiac CaMKII activity by ~40% and preserved left ventricular function after myocardial infarction compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: